EUVIMEDEUVIMED entdecken
Crossref

Piperazine-Structured Lipid Nanoparticles Enable Enhanced Targeted Delivery of SHP-1 siRNA to Macrophages for Treatment of Atherosclerotic Vulnerable Plaques

Pengyu Zhu, Yijun Huang, Liuyan Pan, Yuheng Leng, Hengli Zheng iD, Yongfeng Zhou iD, Weihao Shi, Dapeng Zhang iD, Yongsheng Li iD

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.6c03833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Pengyu Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Low-Dimensional Materials Chemistry, Key Laboratory for Ultrafine Materials of Ministry of Education, Frontier Science Center of the Materials…. Hauptthemen laut MEDLINE: Macrophages, Protein Tyrosine Phosphatase, Non-Receptor Type 6, Nanoparticles, Plaque, Atherosclerotic. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerotic vulnerable plaques pose a risk for acute coronary syndrome and sudden cardiac death due to plaque rupture and thrombosis. While nanomedicines modulating macrophage functions have attracted intensive interest, efficient delivery to plaque macrophages remains challenging. Here, mannose-modified lipid nanoparticles (LNPs) are developed for targeted delivery of a novel SHP-1 (Src Homology 2 Domain-containing Phosphatase-1) siRNA to macrophages within atherosclerotic vulnerable plaques, aiming to enhance macrophage function and stabilize plaques. In ApoE–/– mice with vulnerable plaques, both MIC5 and SM-102 LNPs demonstrated robust plaque targeting capabilities (Cy5 fluorescence reaching ∼1010 p/sec/cm2/sr) and significantly reduced plaque area following SHP-1 siRNA delivery. Importantly, the piperazine-based MIC5 LNPs exhibited enhanced plaque targeting efficiency with M2 macrophage uptake efficiency reaching 46.32% as well as superior therapeutic effects. Collectively, these SHP-1 siRNA-loaded LNPs offer a promising targeted therapeutic strategy for atherosclerotic vulnerable plaques and establish a novel nanoplatform for RNA-based macrophage-modulation in various inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesProtein Tyrosine Phosphatase, Non-Receptor Type 6NanoparticlesPlaque, AtheroscleroticRNA, Small InterferingPiperazinesAnimalsMiceLipidsHumansApolipoproteins ELiposomes

Stichwörter der Autor:innen

SHP-1 siRNAlipid nanoparticlesmacrophagesplaque-targeted deliveryvulnerable plaques

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 6RNA, Small InterferingPiperazinesLipidsPtpn6 protein, mouseLipid NanoparticlesApolipoproteins ELiposomes

Autor:innen und Institutionen

  • Lab of Low-Dimensional Materials Chemistry, Key Laboratory for Ultrafine Materials of Ministry of Education, Frontier Science Center of the Materials Biology and Dynamic Chemistry, School of Materials Science and Engine…
  • Vascular Surgery Division, Department of General Surgery, Huashan Hospital Affiliated to Fudan University, Shanghai200040, China.
  • School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Jiao Tong University, Shanghai200240, China.

ORCID-Profile: Hengli Zheng, Yongfeng Zhou, Dapeng Zhang, Yongsheng Li

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • Shanghai Municipal People's Government

Zitieren

APA

Zhu, P., Huang, Y., Pan, L., Leng, Y., Zheng, H., Zhou, Y., Shi, W., Zhang, D., & Li, Y. (2026). Piperazine-Structured Lipid Nanoparticles Enable Enhanced Targeted Delivery of SHP-1 siRNA to Macrophages for Treatment of Atherosclerotic Vulnerable Plaques. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c03833

Vancouver

Zhu P, Huang Y, Pan L, Leng Y, Zheng H, Zhou Y, et al. Piperazine-Structured Lipid Nanoparticles Enable Enhanced Targeted Delivery of SHP-1 siRNA to Macrophages for Treatment of Atherosclerotic Vulnerable Plaques. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c03833

BibTeX
@article{Zhu2026,
  author = {Zhu, Pengyu and Huang, Yijun and Pan, Liuyan and Leng, Yuheng and Zheng, Hengli and Zhou, Yongfeng and Shi, Weihao and Zhang, Dapeng and Li, Yongsheng},
  title = {Piperazine-Structured Lipid Nanoparticles Enable Enhanced Targeted Delivery of SHP-1 siRNA to Macrophages for Treatment of Atherosclerotic Vulnerable Plaques},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.6c03833}
}
Kostenlos starten →